Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Ionis Pharmaceuticals Inc shares valued at $39,046 were sold by O’NEIL PATRICK R. on Feb 20 ’25. At $32.35 per share, O’NEIL PATRICK R. sold 1,207 shares. The insider’s holdings dropped to 56,245 shares worth approximately $1.93 million following the completion of this transaction.
Also, O’NEIL PATRICK R. sold 6,165 shares, netting a total of over 194,939 in proceeds. Following the sale of shares at $31.62 each, the insider now holds 57,452 shares.
Before that, Monia Brett P had sold 38,843 shares from its account. In a trade valued at $1,229,463, the Chief Executive Officer traded Ionis Pharmaceuticals Inc shares for $31.65 each. Upon closing the transaction, the insider’s holdings decreased to 38,843 shares, worth approximately $6.21 million.
As published in a research note from BMO Capital Markets on August 02, 2024, Ionis Pharmaceuticals Inc [IONS] has been rated down from an Outperform to a Market perform and the price target has been revised to $60 from $67. Analysts at Leerink Partners upgraded the stock from ‘”a Market perform”‘ to ‘”an Outperform”‘ outlook in a report released in late July. Earlier on June 14, 2024, Bernstein upgraded its rating. Their new recommendation was “a Mkt perform” for IONS stock which previously was a “an Underperform”.
Analyzing IONS Stock Performance
During the last five days, there has been a surge of approximately 9.70%. Over the course of the year, Ionis Pharmaceuticals Inc shares have dropped approximately -1.63%. Shares of the company reached a 52-week high of $35.47 on 01/02/25 and a 52-week low of $30.23 on 02/13/25. A 50-day SMA is recorded $33.21, while a 200-day SMA reached $39.77.
Support And Resistance Levels for Ionis Pharmaceuticals Inc (IONS)
According to the 24-hour chart, there is a support level at 33.60, which, if violated, would cause prices to drop to 32.81. In the upper region, resistance lies at 35.09. The next price resistance is at 35.79. RSI (Relative Strength Index) is 60.22 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 1.30, which suggests the price will increase in the coming days. Percent R is at 13.17%, indicating bullish price movement. Stochastics %K at holding indicates that the stock is to be held.
